According to the business intelligence report titled ‘Global Branched Stent Grafts Market Size study, by type (Iliac Stent, Others) by application (EVAR, FEVAR, Chimney, Others)) and Regional Forecasts 2021-2027’, available with Market Study Report, global branched stent grafts market was assessed at USD 260.3 million in 2020 and is anticipated to be worth USD 443 million by 2027, growing at a CAGR of 7.9% between 2021-2027.
 

Growing geriatric population who are prone to chronic or acute health conditions, and preference for minimally invasive surgeries are key growth stimulants for global branched stent grafts market. As per the U.S. Census Bureau, in 2019, the population of the U.S. was 328 million people, of which 75 million were 60 years of age or older, indicating prevalence of various disease cases.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/4006463/
 

Moreover, increasing incidence of aortic aneurysm, coupled with rising adoption of endovascular aneurysm repair procedures are facilitating revenue inflow in this business domain. 
 

For the unversed, branched stent grafts are small metal tubes or scaffolds which have branches or openings that enable the physician to join arteries that are leading to other organs. The graft is taken to the aneurysm spot through a catheter which is implanted via the skin in the groin area.
 

While strong product pipeline will contribute to the market outlook, growing number of product recalls, and high cost of devices & diagnosis will act as challenges for industry partakers.
 

Based on type, worldwide branched stent grafts market is divided into iliac stent, and others. Moving on to application scope, the industry is bifurcated into endovascular aneurysm repair (EVAR), chimney, fenestrated endograft (FEVAR) and others. 
 

Regionally speaking, Asia Pacific market is slated to expand rapidly between 2021-2027, owing to increasing medical tourism, and surging investments in healthcare sector, and presence of modern healthcare infrastructure. Convenience and affordability of healthcare facilities will aid industry expansion as well.
 

Meanwhile, North America held 49% of global branched stent grafts market share in 2021 due to presence of leading companies, favorable reimbursement policies, and advanced healthcare infrastructure. 
 

Key players shaping worldwide branched stent grafts market dynamics are Medtronic plc, Alvimedica, Biotronik GmbH & Co. KG, Endocor GmbH, Merit Medical Systems Inc., Eucatech AG, Cook Medical Incorporated, Abbott Laboratories, Boston Scientific Corporation, and Cardinal Health Inc. (Cordis).